Breast cancer in young patients
Fran Duane,
Ireland;
Ivica Ratosa,
Slovenia
This session will address how carrying BRCA mutations may effect reproductive potential, fertility preservation strategies, and the safety of pregnancy. It will address risk reducing surgery and delve into how loco-regional therapy for those diagnosed with breast cancer may be individualised. Factors influencing surgery and the benefits and risks of breast conservation versus mastectomy will be presented taking into account oncological outcomes, genetic risk factors and patient preferences. Decision-making around adjuvant radiotherapy will be discussed including how novel systemic therapies may modify the radiotherapy landscape. Importantly this symposium will include the patient voice to better understand what is most important to young BRCA carriers in terms of treatment goals and unmet needs.
Symposium
Clinical
Breast